You may have seen viral posts claiming that GLP-1 medications like
Semaglutide or Tirzepatide can “make people fall out of love.”
That sounds dramatic… but neuroscience tells a much different story. SO let's snuff some viral mythological content and drop a little geeky science into the game.
Let’s talk about what’s actually happening in the brain.
☕Grab a cup of coffee and hang in there for this slightly longer lesson post....
🧠The Brain Chemistry of Falling in Love💌
Early romantic love is largely driven by dopamine.
Dopamine is the brain chemical of anticipation, motivation, and pursuit. It activates when your brain senses something exciting or rewarding might happen. But... The dopamine is in the anxiety to get the reward o the reward itself. When we are talking about food...This is why the hamburger doesn't taste as good or leave you as satisfied as wanting it does. The reward is in the obtaining it, not the having it...
This is why the early phase of love feels so intense.
Your brain is basically saying:
🏃♀️“This person is exciting… keep pursuing them.”
In fact, the brain circuits involved in early romantic attraction are very similar to the reward pathways involved in motivation and craving.
This concept is described really well in the book: The Molecule of More by neuroscientist Daniel Z. Lieberman. If you want to really dive in.
But here’s the key point most people miss...
Staying in Love Uses Different Brain Chemistry
Long-term relationships shift away from dopamine-driven excitement and move toward bonding chemistry.
The neurotransmitters that help maintain long-term love include:
• Oxytocin – bonding and trust
• Vasopressin – pair bonding and loyalty
• Serotonin – emotional stability
• Endorphins – comfort and calm
These are the chemicals that support connection, security, and long-term partnership.
So falling in love and staying in love actually use different biological systems.
Where GLP-1 Medications Actually Work
GLP-1 medications were designed to help regulate metabolism, appetite, and blood sugar.
But GLP-1 receptors also exist in areas of the brain that help regulate reward and motivation.
What researchers are seeing is that these medications may help quiet some reward-driven cravings.
People sometimes notice reduced cravings for things like:
• ultra-processed food
• alcohol
• compulsive snacking
• impulsive behaviors
Because of this effect, GLP-1 medications are even being studied for potential use in addiction medicine.
Important distinction:
GLP-1 medications appear to reduce compulsive reward loops, not the bonding chemistry involved in love and relationships.
Why the Internet Thinks It Affects Relationships
Some people report feeling:
• less impulsive
• less reward-driven
• more emotionally steady
If a relationship was heavily built on constant excitement or novelty, dialing down that reward-seeking drive can make things feel different.
But that’s not the same as a medication “turning off love.”
It’s more like the brain shifting from chasing excitement to feeling steady and regulated.
The Takeaway
Falling in love is driven by dopamine and anticipation.
Staying in love is supported by bonding and attachment chemistry.
GLP-1 medications mainly influence metabolic and reward pathways, which can reduce cravings and impulsive behaviors.
They do not turn off the brain’s attachment system.
So the viral claim that GLP-1 medications “make people fall out of love” doesn’t really match what we understand about neuroscience.
The Bigger Insight
The interesting takeaway here is how connected our brain and metabolism really are.
The same reward circuits that influence food cravings also influence motivation, habits, and behavior.
Science is only beginning to understand how deeply these systems are linked.
And sometimes a medication designed for metabolism gives us a fascinating window into how the brain actually works.